Accessibility Statement

Effective September 3, 2026 · Redox

Our commitment to making the Redox Smart Pen website usable by everyone, and how to tell us when it falls short.

Our commitment

Redox Medical Group wants every practitioner and every member of their team to be able to use this website, regardless of ability or the technology they use. We build and test the site against the Web Content Accessibility Guidelines (WCAG) 2.2 at Level AA and we treat accessibility as part of the definition of done for every change we publish.

What we have done

  • Every page uses a logical heading structure and landmark regions so that screen-reader users can move through it quickly.
  • All text meets or exceeds the 4.5:1 contrast ratio required for normal text, including form labels, placeholder text and small print.
  • Every interactive control is reachable and operable with a keyboard, and shows a clearly visible focus indicator.
  • Form fields have visible labels, announce whether they are required, and report errors in text next to the field they relate to.
  • Touch targets are at least 44 by 44 pixels on phones and tablets.
  • Pages can be zoomed to 400 percent without loss of content or horizontal scrolling, and text can be resized in the browser.
  • Images that convey information carry descriptive alternative text; decorative images are hidden from assistive technology.
  • Animation is minimal and respects the operating system's reduced-motion preference.
  • Page performance is optimised so that the site remains usable on slower connections and older devices.

Known limitations

The country selector in the telephone field of our access request form is a component supplied by our form provider. It is keyboard operable and announced by screen readers, but its search and list behaviour may differ from a native browser control. If it presents a barrier, you may leave the country at its default and type your number, or contact us using the email address below and we will complete your request for you.

Compatibility

The site is designed to work with current versions of Chrome, Safari, Firefox and Edge on desktop and mobile, and with the screen readers commonly paired with them, including VoiceOver, NVDA, JAWS and TalkBack. Some visual enhancements, such as the styled dropdown menus on desktop, are applied only where the browser supports them; in all other browsers the standard control is shown.

Tell us about a problem

If you have difficulty using any part of this website, or you have a suggestion that would make it easier to use, please email [email protected] with "Accessibility" in the subject line, or call (310) 421-2707. Tell us the page you were on, what you were trying to do, and the browser and assistive technology you were using. We aim to acknowledge every report within two business days and to fix confirmed barriers as quickly as we can.

About this statement

This statement was prepared on September 3, 2026 following an accessibility review of the site that combined automated testing with manual keyboard, zoom and screen-reader checks. We will review it whenever the site changes materially and at least once a year.

Smart delivery. Better experience. Better outcomes.

For licensed prescribers only. This site is intended solely for healthcare professionals licensed to prescribe in the United States. It is not directed to patients or the general public. Nothing on this site is patient-facing advertising.

Not FDA approved. The Redox Smart Pen is a compounded preparation. Compounded drug preparations are not FDA approved. FDA does not review compounded preparations for safety, effectiveness, or manufacturing quality. The active ingredients described here are not approved by FDA for the uses discussed, and no statement on this site should be read as a claim that any preparation is safe or effective for any condition.

Prescription and dispensing. Any preparation described here would be compounded and dispensed by an independently licensed 503A compounding pharmacy pursuant to a valid prescription for an individually identified patient, based on the prescriber's independent clinical judgment and an established prescriber-patient relationship. Availability is subject to applicable federal and state law, including the status of each ingredient under Section 503A of the Federal Food, Drug, and Cosmetic Act, and may change without notice.

Registration of interest only. Submitting this form registers your interest. It is not an order, a prescription, a purchase commitment, or an offer to sell, and it creates no obligation on either party.

Information only. Content on this site is provided for professional informational purposes and is not medical advice. Prescribers are responsible for evaluating the appropriateness of any therapy for a given patient, for informed consent, and for compliance with all applicable federal and state law, board rules, and professional standards.

Adverse events. Suspected adverse events should be reported to the dispensing pharmacy and to FDA MedWatch at 1-800-FDA-1088 or fda.gov/medwatch.

© 2026 Redox Smart Pen.

Privacy Policy · Terms of Use · Medical Disclaimer · Accessibility